HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US
Date:
02/22/2022
Locations:
Citation:
Patel EU, Genberg BL, Zhu X, Krawczyk N, Mehta SH, Tobian AAR. HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US. JAMA. 2022 Feb 22;327(8):776-777. doi: 10.1001/jama.2022.0293. PMID: 35191936; PMCID: PMC8864507.
Abstract
This study assesses HIV and hepatitis C testing and treatment availability in US specialty substance use disorder treatment facilities that offered medication for opioid use disorder in 2017-2020, stratified between federally certified Opioid Treatment Programs (OTPs) and non-OTPs.